Navigation Links
Pharmaceutical Benefits Scheme Extended for 2 Novel Breast Cancer Drugs

Two new drugs to battle breast cancer have made their way into the Pharmaceutical Benefits Scheme which is a succor for the multitude of sufferers//, who can now avail superior treatment notwithstanding the cost of drugs. This is good news as breast cancer carries the ignominy of being the most common cancer befalling women, affecting 14,000 people annually.

The drugs are targeted at post-menopausal women suffering hormone-dependant early breast cancer, who will be in a position to avail the drug from December 1.

Breast Cancer Network Australia CEO Lyn Swinburne explained that the drugs, called as aromatase inhibitors, were consumed by more than 50% of women suffering breast cancer. Ms Swinburne said "It is important these drugs are on the PBS because they offer women choice. Women shouldn't have to worry about the cost; they have enough decisions to make and options to consider without the added worry of how they are going to pay for these things. What we want is the best treatment for the individual woman to ensure she has the best chance of recovery."

National Breast Cancer Centre acting deputy director Dr Alison Evans said, "Their listing on the PBS is wonderful news as it provides additional treatment options for patients with early breast cancer."


Page: 1

Related medicine news :

1. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Medicis Pharmaceutical company enters pediatric market
4. Pharmaceutical companies are targeting patients
5. FDA approves Watson Pharmaceuticals Oxytrol patch
6. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
7. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
8. Pharmaceutical industries grant for R&D to be monitored
9. Japanese And Chinese Pharmaceutical Companies Join Together In Drug Testing
10. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:

(Date:11/30/2015)... ... November 30, 2015 , ... Brenntag ... exclusive channel partner for the Nutraceutical Specialties products into oral solid dosage in ... immediately. , “We are pleased to announce our expanded distribution agreement with ...
(Date:11/30/2015)... , ... November 30, 2015 , ... An inventor from ... in the womb. "My last baby had high blood pressure due to loud noises," ... to protect their babies from noise pollution as well as radio waves and microwaves." ...
(Date:11/30/2015)... ... November 30, 2015 , ... Since its inception, ... in independent living, assisted living and all other retirement options. Support for issues ... and research remains a top priority. , So it’s no surprise that ...
(Date:11/30/2015)... ... 30, 2015 , ... Sikka Software announced today that they are showcasing the ... to make complex business decisions by providing the tools and information they need to ... with 10 procedures customized by zip code. , The Sikka Software Ecosystem includes ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... the assets of DataTrade Solutions Inc., a Healthcare IT consulting, development and support ... the programming and technical experience available within DataTrade to extend the services currently ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... NEW YORK , November 27, 2015 ... health system is set to go online. The potential ... and processes is vast and far from fully exploited ... access to patient health records, either via mobile tablet ... ) --> ) ...
(Date:11/27/2015)... PHILADELPHIA , Nov. 27, 2015  Lannett ... that it has completed the acquisition of Kremers ... pharmaceuticals subsidiary of global biopharmaceuticals company UCB S.A. ... --> Lannett has acquired KU from UCB ... to certain adjustments, including a customary working capital ...
(Date:11/27/2015)... 2015 ... "2016 Global Tumor Marker Testing Market: ... Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, ... their offering. --> ) ... "2016 Global Tumor Marker Testing Market: Supplier ...
Breaking Medicine Technology: